Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOUNTAIN: Zuranolone in Major Depressive Disorder
NCT03672175Phase 3Completed
- Sponsor
- Biogen
- Start
- Nov 2018
- Primary completion
- Sep 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of zuranolone in major depressive disorder (MDD), sponsored by Biogen. Started Nov 2018; status: completed.
02
Drugs
zuranolone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03672175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672175.